MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with N

Norethisterone

Norethisterone 5mg tablets

No stability information

Stability notes for Norethisterone 5mg tablets

There are no stability notes for this medicine.

Suppliers (8) of Norethisterone 5mg tablets
Norethisterone 5mg tablets (A A H Pharmaceuticals Ltd)
Norethisterone 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Norethisterone 5mg tablets (Key Pharmaceuticals Ltd)
Norethisterone 5mg tablets (Medihealth (Northern) Ltd)
Norethisterone 5mg tablets (Sigma Pharmaceuticals Plc)
Norethisterone 5mg tablets (Wockhardt UK Ltd)
Primolut N 5mg tablets (Bayer Plc)
Utovlan 5mg tablets (Pfizer Ltd)

Norethisterone 350microgram tablets

No stability information

Stability notes for Norethisterone 350microgram tablets

There are no stability notes for this medicine.

Supplier

Noriday 350microgram tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.